Fine Americas Inc. Overview
Fine Americas, Inc. is a specialist supplier of plant growth regulators (PGRs) to the North and South American market. It is not a broad-line crop-protection company. Its focus is the narrow, technically demanding PGR niche, serving two customer sets. The first is greenhouse ornamental growers, who use PGRs to control height, branching and flowering for retail-ready plants. The second is high-value tree-fruit growers (apples, pears, cherries, citrus, grapes), who use PGRs for fruit thinning, sizing, russet control and drop control. Fine works almost entirely with off-patent active ingredients such as paclobutrazol, daminozide, uniconazole, ethephon, chlormequat, 6-benzyladenine, gibberellins and NAA. It competes through proprietary formulation (for example, clear paclobutrazol and high-concentration 6-BA), label expansion, grower-facing technical research and a reputation for quality. Since 2014 it has been part of France's De Sangosse Group. This gives Fine access to a wider biocontrol, crop-nutrition and pest-control portfolio and sister companies in the US, such as Nutrient Technologies.
Company's own description
Fine Americas describes itself on its website and on supplier platforms such as Knowde and the MSU symposium sponsor page in these terms:
-
It develops, manufactures and markets PGRs for agricultural, greenhouse ornamental and landscape markets.
-
It calls itself a center of excellence for PGR technology.
-
It says it serves quality-conscious growers in more than 40 countries.
-
It describes an ongoing investment program in new products, new uses and product value enhancement.
Its current homepage presents the company as a team of dedicated scientists creating PGRs for ornamental and fruit crops. (Source: fine-americas.com, accessed Oct 2026; Knowde store profile; MSU 2025 Fruit Bioregulator Symposium sponsor page.)
Independent characterization
Fine Americas is a formulation-, registration- and market-access business. It is not a discovery-chemistry company. Its value chain works as follows:
-
Active ingredient sourcing. It buys generic or off-patent technical-grade actives. Trade press has confirmed that its core ornamental products are off-patent chemistries.
-
Formulation and registration. Fine Agrochemicals Ltd. holds the US EPA FIFRA Section 3 registrations (company number 62097). Fine Americas manages state registrations, such as those in California and New York, through its Walnut Creek regulatory staff.
-
Technical marketing. It invests heavily in agronomic trial data, university collaborations and grower guides, such as the PGR Guide for Perennials, to create pull-through demand.
-
Distribution. It sells through horticultural and agricultural distributors rather than directly to most growers. For example, it uses Royal Brinkman Canada for Canadian greenhouse customers.
Revenue model
| Revenue stream | Description | Estimated share |
|---|---|---|
| Product sales: ornamental PGRs | Greenhouse, nursery and landscape PGR concentrates sold through distributors | — |
| Product sales: fruit / specialty-crop PGRs | Thinning, sizing, finish and drop-control products for tree fruit, grapes and citrus | — |
| Services | Technical advisory, trial support and grower education. These are bundled with product sales and not monetized separately. | — |
| Licensing / subscription | None identified | — |
Customer types and end-markets
-
Commercial greenhouse ornamental growers, including bedding plants, poinsettias, perennials, potted flowering crops and bulbs.
-
Nursery and landscape growers, including woody ornamentals.
-
Tree-fruit growers, including apples, pears and sweet cherries, especially in Washington, Michigan, New York, Pennsylvania, Virginia, Oregon and California.
-
Grape and citrus growers, served through GA3 products.
-
Distributors, who are the immediate customers. Examples include Royal Brinkman Canada and regional ag-retail and horticultural distributors.
Latin America (South America): Leadership statements from 2017 describe growth in the Fine Americas brand in North and South America.
Strategy
There is no annual report or investor day. Strategy is inferred from company statements and observed actions.
Stated strategic themes (paraphrased from company materials):
-
PGR specialization. Management has emphasized that the company focuses on PGRs alone, and positions this as the basis for its technical leadership.
-
Continuous investment in new products, new uses (label expansions) and product value enhancement.
-
Quality through ISO 9001 manufacturing controls maintained across the supply chain.
-
Americas market expansion across the US, Canada and South America.
-
Group synergy. In 2017, management framed the combination with Nutrient Technologies as a way to channel De Sangosse nutrition, biostimulant and PGR technologies to North American farmers.
Observed initiatives (last 24 months):
- ESG commitments, cost programs and medium-term financial targets: Not publicly disclosed.
Products & Services
Pricing for all products is not publicly disclosed. Fine sells through distributors.
Ornamental & Landscape PGRs
| Product | Active ingredient / type | Function and target crops | Launch / latest version | Source |
|---|---|---|---|---|
| Dazide (incl. Dazide 85WSG) | Daminozide | Produces greener, stronger, more compact plants. Widely used on bedding and potted crops and can be tank-mixed with Citadel for synergy. | Mid-2000s US launch | Greenhouse Canada; Greenhouse Grower |
| Piccolo | Paclobutrazol | Height control | Mid-2000s | Greenhouse Grower |
| Piccolo 10XC | Paclobutrazol, higher concentration | Height control. Marketed as a clear paclobutrazol solution. | Late 2000s–2010s | Greenhouse Canada; PerishableNews |
| Concise | Uniconazole | Denser plants with longer shelf life | Mid-2000s; state registrations rolled out progressively | Greenhouse Grower; Greenhouse Canada |
| Collate | Ethephon (concentrated) | Increases lateral branching, delays flowering and inhibits internode elongation. Also controls height and stem topple in daffodil and hyacinth. Valued for reducing labor (mechanical pinching). | Undated US introduction | Greenhouse Grower; Greenhouse Management |
| Configure | 2% 6-benzyladenine (N-(phenylmethyl)-1H-purine-6-amine) | Branching and flowering in Christmas cactus, hosta (including propagation offsets) and echinacea. Ready-to-mix spray. | Described as the first registered 2% formulation of this AI | Greenhouse Grower |
| Citadel | 11.8% chlormequat chloride | Height control in poinsettias, geraniums, azaleas, hibiscus and bedding plants. Produces darker foliage, thicker leaves and stronger stems for shipping. | Undated | Greenhouse Grower |
| Fresco | Cytokinin/gibberellin PGR | Revitalizes over-regulated or stalled crops such as lilies and poinsettias. Supports healthier foliage and bract quality. For indoor or outdoor use. | Core line since mid-2000s; featured Jan 2026 | GrowerTalks; Greenhouse Grower |
| Florgib | Gibberellic acid (GA3) | Ornamental gibberellin applications | Mid-2000s | Greenhouse Grower |
Fruit & Specialty Crop PGRs
| Product | Active ingredient | Function and target crops | EPA Reg. / latest label | Source |
|---|---|---|---|---|
| Exilis | 6-BA | Post-bloom apple thinning and fruit weight. Early registration covered MI, NY, OR, PA and VA. | 62097-8 (2000) | US EPA |
| Exilis Plus | 6-BA | Post-bloom apple thinning and sizing. Marketed as having the highest % of 6-BA labeled for apples and pears. | 62097-9 (2005 label) | US EPA; Growing Produce |
| Exilis 5 XL (ABN Exilis 9.5 SC) | 6-BA | Post-bloom thinning in apples and pears. Can increase branching and feathering in apple, pear and non-bearing cherry nursery trees. | 62097-33; amended Apr 2023 and Jul 2024 | US EPA |
| Novagib 10L | GA4 (+GA7 per label class) | Reduces climatic russeting in apples, controls Stayman cracking and sizes sweet cherries (added 2016). OMRI-listed. | 62097-7; amended 2010 and 2016 | US EPA; Growing Produce |
| Novagib 5L | GA4 | Apple russet reduction (lower concentration) | 62097-47; amended Aug 2022 | US EPA |
| Perlan | GA4 + 6-BA | Improves typiness (shape) and size of apples | Undated | Growing Produce |
| Refine | Naphthaleneacetic acid (NAA) | Thinning, pre-harvest drop control and return bloom in apples and pears. Also labeled for citrus and olives. | Section 3 registration Mar 2015 | Fruit Growers News |
| Falgro | GA3 | Quality and yield in grapes, citrus and cherries | Undated | Growing Produce |
| Blush | — | Fruit PGR (named in product list) | — | Fruit Growers News |
| Kudos | — | Fruit PGR (named in product list) | — | Fruit Growers News |
| Motivate | — | Fruit PGR (named in product list) | — | Fruit Growers News |
Services
| Service | Description |
|---|---|
| Technical services | A field technical services team supports growers with trials and rate guidance. Named managers over time include Kevin Forney and Jim Scruggs. |
| Regulatory services | A technical and regulatory services coordinator role was created to support label expansion and testing. |
| Grower education | The PGR Guide for Perennials (2020–21 edition) is a crop-by-crop rate table. It was developed with researchers at Virginia Tech (Latimer) and NC State (Whipker). |
| Third-party comparison testing | Fine has historically provided comparison data against competing PGRs, while encouraging growers to run their own trials. |
Financial Narrative
Fine Americas is a private subsidiary and publishes no financial statements. It is consolidated within De Sangosse, which does not publish consolidated accounts at a subsidiary level. Every audited line item below is therefore not publicly disclosed (NA). The only available revenue datapoint is a third-party aggregator estimate of about USD 30M (RocketReach, 2026). It is unaudited and cannot be verified, so it is excluded from the chartable tables.
Margins
Revenue CAGR (FY2021–FY2025): not publicly disclosed.
Parent-level reference data (De Sangosse; not Fine Americas)
These figures are shown only for context on the parent's scale. They are not Fine Americas figures, and the sources conflict.
Source: Businesscoot, from French registry filings (FYE 31 Aug). Le Journal des Entreprises separately shows a later statutory turnover of about EUR 140.4M with net profit of about EUR 19.9M, but the year is not clearly labeled.
Commentary
No trend analysis based on filings is possible. Indirect indicators of commercial trajectory are:
-
Continued investment in label maintenance and expansion, with EPA amendments in 2022, 2023 and 2024.
-
Platinum-tier sponsorship of an international fruit bioregulator symposium in 2025.
-
Ongoing product promotion in 2026.
Together, these point to a stable, actively managed franchise rather than a run-off business. The roughly 10-person headcount estimate suggests a lean commercial, technical and regulatory hub. Manufacturing and formulation are likely carried out by group facilities or toll manufacturers (not publicly disclosed). Revenue per employee implied by the aggregator estimate would be about USD 3M.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
De Facto Segment Details
| De facto segment | Contents | Key products |
|---|---|---|
Ornamental & Landscape PGRs | Greenhouse, nursery and landscape height control, branching and flowering | Piccolo, Piccolo 10XC, Dazide, Concise, Collate, Configure, Citadel, Fresco, Florgib |
Fruit & Specialty Crop PGRs | Fruit thinning, sizing, russet control, fruit finish, drop control and return bloom | Exilis Plus, Exilis 5 XL, Novagib 10L/5L, Perlan, Refine, Falgro, Blush, Kudos, Motivate |
Income Statement
| Metric | FY2015 | FY2016 | FY2017 | FY2018 | FY2019 |
|---|---|---|---|---|---|
De Sangosse SAS statutory turnover (EUR Mn) | 199.5 | 118.0 | 101.2 | 96.4 | 85.4 |
De Sangosse SAS statutory net profit (EUR Mn) | 15.9 | 15.5 | 7.1 | 6.5 | 6.7 |
Capital Markets
| Item | Status |
|---|---|
Share price performance (1/3/5-year) | Not applicable (private) |
P/E, EV/EBITDA, EV/Sales, P/B | Not applicable (private) |
Analyst consensus | None. There is no analyst coverage. |
Dividend history / policy | Not publicly disclosed (intra-group) |
Credit ratings (Moody's / S&P / Fitch) | Not rated |
Parent credit indicator | A French registry aggregator assesses De Sangosse SAS's default risk as very low and says the majority shareholder has strong financial capacity (Le Journal des Entreprises; unaudited third-party score) |
Metric | FY2021 |
Analyst Conclusions
Management guidance: None published.
Consensus expectations: None. There is no coverage.
Bull case
-
Volume tailwind from fruit. A larger US apple crop (about 279M bushels forecast for 2025–26 versus about 260M) and the expansion of cherry sizing and nursery-feathering labels should lift demand for Exilis and Novagib.
-
Labor economics favor PGRs. Documented grower adoption of Collate + Dazide to replace hand pinching links demand to structural labor-cost inflation.
-
Parent synergies. De Sangosse's nutrition, biostimulant and biocontrol lines could be cross-sold through Fine's grower relationships, as management framed in 2017.
Bear case
-
Commoditization. Off-patent actives leave Fine exposed to low-cost generics, with only formulation and service as defenses.
-
Regulatory attrition. Registration review of legacy actives could narrow labels or remove products, and a small regulatory team must defend many registrations.
-
Scale limits. A roughly 10-person organization competes against multinational suppliers with far larger field forces and R&D budgets.
Key catalysts and monitorables (next 12 months)
-
New EPA label amendments or Section 3 registrations under company number 62097.
-
Leadership announcements at Fine Americas or Nutrient Technologies, including confirmation of current presidency.
-
Any De Sangosse reorganization of North American subsidiaries.
-
The 2027 spring fruit-thinning season and the US apple crop forecast.
-
New ornamental product introductions in GrowerTalks and Greenhouse Grower.
-
EPA registration review decisions on paclobutrazol, daminozide, chlormequat and ethephon.
Analyst verdict
Fine Americas, Inc. is not a public company, and any workflow that treats it as one should be corrected. It is a small, privately held, wholly owned US subsidiary of the UK-based Fine Holdings group, which France's family-controlled De Sangosse Group has owned since July 2014. It has no listed securities, no SEC disclosure and no audited standalone financials in the public domain. The only revenue indicator, an aggregator estimate of about USD 30M, should be treated as indicative at best.
Operationally, the business is coherent and durable. Fine has built a credible niche franchise in plant growth regulators across two complementary markets: greenhouse ornamentals and high-value tree fruit. Its moat does not come from molecule patents, since its core actives are off-patent. It comes from four accumulated assets:
-
a portfolio of maintained federal and state registrations;
-
distinctive formulations;
-
a reputation for technical service built over decades with universities and growers;
-
trademarks that are well known in their niche, such as Piccolo, Dazide, Exilis and Novagib.
Continued EPA label activity through 2024 and visible market investment in 2025–26 indicate that the parent continues to fund the franchise.
The main risks are structural: generic price pressure, regulatory review of legacy chemistries, and the fragility of a very lean organization. The main opportunities are labor-driven adoption in greenhouses, a recovering US apple crop, and cross-selling within the De Sangosse group.
For counterparty, supplier or competitive-intelligence purposes, Fine Americas should be assessed as a stable specialist backed by a solid parent, not as an investable security. Any credit or commercial exposure should be underwritten at the De Sangosse group level, with direct confirmation of current leadership and financials requested from the company.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Executive Leadership Team
| Name | Title (as last reported) | Tenure / context | Prior roles / education | Source |
|---|---|---|---|---|
Greg Johnson | President, Fine Americas; also led Nutrient Technologies from Dec 2017 | Joined Fine in 2004 and promoted from VP Sales & Marketing to President | Arysta LifeScience (Director of Global Marketing; Director of Business Operations Western Hemisphere); AgriDyne Technologies; CIBA-GEIGY | Fruit Growers News; Nursery Management; Greenhouse Grower |
Julian Ward | Managing Director, Fine Holdings Group (UK) | Reported in 2017 | — | Fruit Growers News |
Nicolas Fillon | CEO / Président, De Sangosse Group | Reported in 2017 and in registry data | — | Fruit Growers News; Businesscoot |
Christophe Maquin | President of the Supervisory Board, De Sangosse | Current registry listing | — | Le Journal des Entreprises |
Jim Scruggs | Technical Services Manager | Reported in 2010s | — | Greenhouse Management; Fruit Growers News |
Kevin Forney | Technical Services / Technical Manager | Earlier period | — | Greenhouse Grower |
Andrew (Drew) Hubbard | Technical & Regulatory Services Coordinator | Undated hire | BS in Production Horticulture (University of Illinois); MS in Plant Pathology (Oregon State); previously at G.S. Long Co., Yakima | Greenhouse Management |
Jolanta Ozatalay | Regulatory Manager | EPA correspondence 2022–2024 | — | US EPA |
Donette Faulk | Sales Manager | Undated appointment | — | Greenhouse Grower |
Dan Skoczylas | Director of Business Development, North America | Current per aggregator | — | RocketReach |
“—” = not publicly disclosed.
Major Shareholders
| Holder | Stake | Note |
|---|---|---|
De Sangosse Group (via Fine Holdings Ltd) | 100% (wholly owned subsidiary) | Fine Americas is described as wholly owned by Fine Holdings Ltd; the group was acquired by De Sangosse in July 2014 |
Competitive Landscape
Key Competitors
| Competitor | Segment overlap | Positioning vs. Fine |
|---|---|---|
Valent BioSciences (Sumitomo Chemical) | Fruit and ornamental PGRs (gibberellins, 6-BA/GA combinations, ACC-based thinners, ReTain AVG) | Market leader in biorational PGRs with a much larger scale and R&D base |
Fine Holdings' generic-PGR peers: Nufarm | Ornamental and fruit PGRs (generic ethephon, gibberellins) | Broader generic portfolio and larger distribution reach |
OHP, Inc. | Greenhouse ornamental PGRs (e.g., paclobutrazol, uniconazole products) | Direct ornamental competitor focused on greenhouse and nursery |
SePRO Corporation | Ornamental PGRs (e.g., paclobutrazol, flurprimidol) and landscape/turf growth regulators | Strong in greenhouse and landscape |
Bayer Crop Science | Ethephon and other PGRs (ag and fruit) | Large-cap, broad portfolio |
BASF | Prohexadione-calcium (Apogee/Kudos-class) for fruit; mepiquat in row crops | Major in fruit vegetative growth control |
AMVAC (American Vanguard) | Ag PGRs and NAA-type products | Mid-cap US ag-chem |
Corteva Agriscience | Fruit and ag chemicals (adjacent) | Broad portfolio, indirect competitor |
Arysta LifeScience legacy (now UPL) | Ethephon and fruit PGRs | Large generic player |
Fine Americas' generic AI resellers (various) | Paclobutrazol, daminozide, ethephon generics | Price-based competition on off-patent actives |
Peer Comparison FY2019
| Metric | Fine Americas | Valent BioSciences | Nufarm (group) | SePRO |
|---|---|---|---|---|
Revenue | Not publicly disclosed (about USD 30M aggregator estimate) | Not separately disclosed (inside Sumitomo) | — | Not publicly disclosed (private) |
PGR focus | PGR pure-play | Biorationals and PGRs | Diversified crop protection | Aquatics, ornamentals, turf |
Recent Developments
*Earlier, still-relevant regulatory items: an EPA label revision for Exilis 5 XL (receipt Mar 2024, approved Jul 2024) and an Apr 2023 amendment.
*Not identified in public sources: leadership changes, guidance revisions, litigation, layoffs, restructurings or contract wins in the 18-month window.



